These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28974448)

  • 1. Integrating T cell metabolism in cancer immunotherapy.
    Dugnani E; Pasquale V; Bordignon C; Canu A; Piemonti L; Monti P
    Cancer Lett; 2017 Dec; 411():12-18. PubMed ID: 28974448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging concepts of T cell metabolism as a target of immunotherapy.
    Chang CH; Pearce EL
    Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprograming of anti-tumor immunity.
    Sukumar M; Kishton RJ; Restifo NP
    Curr Opin Immunol; 2017 Jun; 46():14-22. PubMed ID: 28412583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
    Bahrambeigi S; Shafiei-Irannejad V
    Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Barriers to T Cell Function in Tumors.
    Sugiura A; Rathmell JC
    J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer.
    Shevchenko I; Bazhin AV
    Front Immunol; 2018; 9():1816. PubMed ID: 30131808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
    Kishton RJ; Sukumar M; Restifo NP
    Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
    Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
    Front Immunol; 2021; 12():645242. PubMed ID: 33815400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries.
    Ho PC; Kaech SM
    Curr Opin Immunol; 2017 Jun; 46():38-44. PubMed ID: 28458087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Complex Interplay Between T Cell Metabolism and Function.
    Geltink RIK; Kyle RL; Pearce EL
    Annu Rev Immunol; 2018 Apr; 36():461-488. PubMed ID: 29677474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies of antigen-specific T-cell-based immunotherapy for cancer.
    Liu SH; Zhang M; Zhang WG
    Cancer Biother Radiopharm; 2005 Oct; 20(5):491-501. PubMed ID: 16248765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of the fittest: Cancer challenges T cell metabolism.
    Franchina DG; He F; Brenner D
    Cancer Lett; 2018 Jan; 412():216-223. PubMed ID: 29074426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic Competition in Tumor Microenvironment].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional T cell metabolism in the tumor microenvironment.
    Beckermann KE; Dudzinski SO; Rathmell JC
    Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting T cell metabolism for immunotherapy.
    Gao J; Liu Y; Wei J; Jiang L; Mao J; Chang CH; Wu D
    J Leukoc Biol; 2021 Dec; 110(6):1081-1090. PubMed ID: 34779530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.